Phase 3
Completed N=118
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
Scabies · Head Lice
Source: ClinicalTrials.gov NCT03236168 ↗
Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcomePrimary: Number of Participants With Headlice — 3 Participants
◆ Published Evidence
Established
25citations · ~3 / year
Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.
Summary
This is a pilot study evaluating if treatment for scabies also treats headlice in the same community
Linked Publications
-
Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Headlice |
— | — |
| SECONDARY Number of Participants With Headlice |
— | — |
Eligibility Criteria
Inclusion Criteria
- All participants living in the community will be offered treatment
Exclusion Criteria
- Patients with a contradindication to study medication
- Patients unable to provide consent
Data sourced from ClinicalTrials.gov (NCT03236168) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.